Decibel Therapeutics, Inc. Quarterly Depreciation in USD from Q1 2020 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Decibel Therapeutics, Inc. quarterly/annual Depreciation history and growth rate from Q1 2020 to Q1 2023.
  • Decibel Therapeutics, Inc. Depreciation for the quarter ending March 31, 2023 was $340K, a 7.36% decline year-over-year.
  • Decibel Therapeutics, Inc. annual Depreciation for 2022 was $1.46M, a 3.47% increase from 2021.
  • Decibel Therapeutics, Inc. annual Depreciation for 2021 was $1.41M, a 13.9% decline from 2020.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $340K -$27K -7.36% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q1 2022 $367K -$60K -14.1% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $427K -$60K -12.3% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $487K Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.